Biotech startups in Tel Aviv, Israel
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Scala Biodesign | Tel Aviv | Series A | $16.0M | 2026-03-31 |
| CytoReason | Tel Aviv | Series B | $80.0M | 2024-07-17 |
| Imagene AI | Tel Aviv | Series B | $23.0M | 2025-07-01 |
| Protai | Tel Aviv | Seed | $12.0M | 2023-03-15 |
| Quris | Tel Aviv | Seed | $9.0M | 2022-12-20 |
| Newmoo | Tel Aviv | Seed | $7.0M | 2024-05-28 |
| NeuroBrave | Tel Aviv | Angel | $300K | 2022-08-19 |
| Myndlift | Tel Aviv | Series A | $3.9M | 2020-12-30 |
8 rows of the CSV in 5 of its 18 columns.
- The 42 biotech startups in Tel Aviv, Israel have raised $335.9M in total.
- 4 of them closed their most recent round in the last 12 months, $25.6M combined.
- The largest of those rounds is Scala Biodesign's $16.0M Series A, dated March 2026.
- The most recent is SuperMeat's $6.0M Series A on 12 May 2026.
- Intel Ignite is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 32 companies (76%).
- 38% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 11 to 50 employees (59% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 42| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Scala Biodesign | Scala Biodesign provides partners with a computational solution that increases the value of proteins and speeds their development. | Artificial intelligence | Series A | $16.0M | 2026-03-31 | $26.2M | Intel Capital, Intel Ignite, TLV Partners | 1 to 10 | 2022 |
| CytoReason | CytoReason develops a cell-centered computational model of the human body to find patterns in biological data. | Artificial intelligence | Series B | $80.0M | 2024-07-17 | $100.0M | OurCrowd, Asymmetry Ventures, Pfizer | 101 to 250 | 2016 |
| Quris | Quris provides an AI platform that predicts which drug candidates will safely work in humans. | Artificial intelligence | Seed | $9.0M | 2022-12-20 | $37.0M | SoftBank Vision Fund, iAngels, Fusion +1 | 11 to 50 | 2019 |
| NeuroBrave | NeuroBrave provides access to real-time cognitive and emotional states through everyday wearable devices. | Artificial intelligence | Angel | $300K | 2022-08-19 | Intel Ignite, Samurai Incubate, Italian Angels for Growth +2 | 11 to 50 | 2020 | |
| MobileODT | MobileODT develops AI-based medical devices for cervical cancer screening. | Artificial intelligence | Series C | $4.0M | 2020-08-12 | MedTech Innovator, OrbiMed, VU Venture Partners +2 | 11 to 50 | 2012 |
Table 1. Biotech startups in Tel Aviv, Israel: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 42.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Scala Biodesign | Scala Biodesign provides partners with a computational solution that increases the value of proteins and speeds their development. | Artificial intelligence | Series A | $16.0M | 2026-03-31 | $26.2M | Intel Capital, Intel Ignite, TLV Partners | 1 to 10 | 2022 |
Table 2. Biotech startups in Tel Aviv, Israel: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Intel Ignite | Startup accelerator | Tel Aviv, Israel | 2 | 5% | 1 | Scala Biodesign |
| 2 | TLV Partners | Venture capital firm | Tel Aviv, Israel | 1 | 2% | 1 | Scala Biodesign |
| 3 | Intel Capital | Corporate venture arm | Santa Clara, United States | 1 | 2% | 1 | Scala Biodesign |
| 4 | Asymmetry Ventures | Venture capital firm | San Francisco, United States | 1 | 2% | ||
| 5 | Pfizer | Corporate venture arm | New York, United States | 1 | 2% | ||
| 6 | OurCrowd | Venture capital firm | Jerusalem, Israel | 1 | 2% | ||
| 7 | Blumberg Capital | Venture capital firm | San Francisco, United States | 1 | 2% | ||
| 8 | Pitango VC | Venture capital firm | Herzliya, Israel | 1 | 2% | ||
| 9 | Grove Ventures | Venture capital firm | Tel Aviv, Israel | 1 | 2% | ||
| 10 | Maj Invest Equity | Private equity firm | Copenhagen, Denmark | 1 | 2% | ||
| 11 | iAngels | Angel group | Tel Aviv, Israel | 1 | 2% | ||
| 12 | Fusion | Startup accelerator | Santa Monica, United States | 1 | 2% | ||
| 13 | SoftBank Vision Fund | Private equity firm | London, United Kingdom | 1 | 2% | ||
| 14 | GlenRock Israel | Private equity firm | Herzliya, Israel | 1 | 2% | ||
| 15 | European Commission | Government investment office | Brussels, Belgium | 1 | 2% |
Table 3. Biotech startups in Tel Aviv, Israel: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 32 | 76% | $305.5M |
| Software | 15 | 36% | $213.6M |
| Artificial intelligence | 12 | 29% | $207.7M |
| Hardware | 3 | 7% | $37.0M |
| Education | 1 | 2% | $3.4M |
Table 4. Biotech startups in Tel Aviv, Israel by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 1 | 2% | |
| Seed | 25 | 60% | $4.4M |
| Series A | 6 | 14% | $6.0M |
| Series B | 7 | 17% | $23.0M |
| Series C | 2 | 5% | $18.0M |
| Series D+ | 1 | 2% | $26.0M |
Table 5. Biotech startups in Tel Aviv, Israel by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| May 2026 | 2 | 50% | $9.6M |
| March 2026 | 1 | 25% | $16.0M |
| December 2025 | 1 | 25% |
Table 6. Biotech startups in Tel Aviv, Israel: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 3 | 7% | $25.6M |
| 2025 | 5 | 12% | $35.2M |
| 2024 | 3 | 7% | $87.0M |
| 2023 | 7 | 17% | $59.7M |
| 2022 | 8 | 19% | $184.3M |
| 2021 | 4 | 10% | $11.2M |
Table 7. Biotech startups in Tel Aviv, Israel by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 16 | 38% |
| 2015 to 2019 | 15 | 36% |
| 2010 to 2014 | 9 | 21% |
| Before 2010 | 2 | 5% |
Table 8. Biotech startups in Tel Aviv, Israel by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 15 | 37% |
| 11 to 50 | 24 | 59% |
| 51 to 100 | 1 | 2% |
| 101 to 250 | 1 | 2% |
Table 9. Biotech startups in Tel Aviv, Israel by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Tel Aviv, Israel. On 16 November 2026 that is 42 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 42 rows: 13 have no round amount, 0 no city and 9 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Tel Aviv, Israel are on the list?
- 42, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 42 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.